Clario’s Post

View organization page for Clario, graphic

96,443 followers

2mo Edited

Clario is delighted to announce the official opening of our new office in Budapest, Hungary! We marked the occasion with a ribbon-cutting ceremony led by members of Clario’s executive leadership team, including our EVP of Medical Imaging, Joyce Suhy, PhD, our EVP of Cardiac and Respiratory Solutions, Ellen Street (Conway), our Chief Information, Technology and Product Officer, Jay Ferro, and our Chief Medical Officer, Todd Rudo, M.D. The two-day celebration was organized by Clario’s lead in Hungary, Janos Toth, with support from many enthusiastic local employees. Special thanks to Janos and everyone who made the opening a great success! We can't wait to see what incredible achievements the future holds for Clario in Budapest! Learn more about life at Clario: https://hubs.li/Q024NJP_0 #ClarioBudapest #ClinicalTrials #BudapestOfficeOpening

2 Comments

Curtis Szmania

Founder & CEO at CytoCync | Introducing Productized Health Software Services

1mo

Congratulations to @Clario on the grand opening of your new office in Budapest. Thrilled to see your continued growth and expansion in the HealthTech industry. Your executive leadership team's presence at the ribbon-cutting ceremony speaks volumes about your commitment. Best wishes for a successful and productive future in Budapest. As a fellow leader in the HealthTech space, I'm curious to know how you plan to leverage this new location to drive innovation and growth

Bouzegaou Nadia

Radiologist, Director radilogy services at Synarc

1mo

Great news!

See more comments

To view or add a comment, sign in

More Relevant Posts

Clario

96,443 followers
2d
Report this post
The European Union AI Act has just been published! For more insights on this significant development in #AI regulation, check out this post by our Chief AI Officer, Marko Topalovic. ⬇

Marko Topalovic

Chief AI Officer @ Clario | Harnessing artificial intelligence and machine learning to transform clinical trial endpoint analysis and the sponsor experience
2d

It’s official! The European Union AI Act has just been published. It marks a significant development in the regulation of artificial intelligence technologies. This legislation aims to set comprehensive standards for the ethical and responsible deployment of AI, addressing several critical areas. At Clario, we are taking all aspects of #AI very seriously. Compliance with any regulation, including the new AI Act, is of utmost importance to us. We are committed to ensuring all our AI technologies adhere to these standards, fostering a trustworthy and reliable environment for patients and study sponsors. As a reminder, key elements of the AI Act: - Risk-based approach: Obligations for providers and users are laid out depending on the AI system’s level of risk. - Transparency and Accountability: The Act requires clear guidelines to ensure transparency in AI systems, enabling users to understand the basis of AI-driven decisions. - Ethical Considerations: Emphasizes the importance of ethical AI development, focusing on fairness, mitigation of biases, and respect for human rights. - Safety and Security: Robust measures are introduced to manage risks, enhance cybersecurity, and prevent the misuse of AI technologies. The AI Act is a crucial step in ensuring that AI technologies are developed and utilized responsibly. Even though regulation is seen as a bottleneck to innovation, I believe in the opposite. It will help us to safeguard high-quality innovation, especially in sensitive industries such as healthcare and life science where we are involved daily and it will help sustain the credibility and trustworthiness of all upcoming AI breakthroughs. I am looking forward to seeing the collaborative work of all stakeholders across sectors in implementing these guidelines. Special thanks to the amazing team at Clario who is ensuring the right governance of #AI Tancredi Vergani, Lauren Misztal, Todd Rudo, Gaurav Josan and Jay Ferro. How do you see the new Act impacting the future of AI development? https://lnkd.in/e4eWDAxb

Choose the experimental features you want to try

eur-lex.europa.eu
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
3d Edited
Report this post
The integration of efficacy, safety, and quality of life data maximizes the overall value of a clinical trial, enabling an inclusive assessment of benefits and risks, and ensuring that novel cancer therapies meet patients’ needs holistically. That’s the argument made in an article by Clario's Chief Medical Officer, Todd Rudo, M.D.; Chief Science and Regulatory Advisor-Cardiology, Robert B. Kleiman MD, M.D.; and Director of eCOA Science, Kelly Dumais, Ph. D. Check out the article for their guidance on how to design oncology trials for a comprehensive understanding of the therapeutic impact and patient quality of life in the development of new oncology drugs. ➡️ https://hubs.li/Q02GbGmt0 #clinicaltrials #oncology #drugdevelopment
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
4d Edited
Report this post
Last call to register! 📣 Secure your spot today for our webinar: “Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility and Advanced AI-driven Analysis.” Join Clario's experts Todd Rudo, Amit Vasanji, and Kelly Dumais as they explore strategies to enhance patient access and precision analysis using artificial intelligence (AI) in ophthalmology clinical trials. They will delve into vendor-agnostic, multi-modality platforms, AI-enabled workflows, and best practices for eCOA implementation in various trial settings. ➡️ Register here: https://hubs.li/Q02G10d70 #AI #artificialintelligence #clinicaltrials

1 Comment
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
5d Edited
Report this post
Interested in new frontiers in respiratory clinical trials? 👇 Check out our free on-demand webinar! In this video, Clario's new SVP and Chief AI Officer, Marko Topalovic; Director of Scientific Affairs, Kevin McCarthy; and Senior Director of Respiratory Solutions, Philip Lake, Ph. D., discuss: - Cutting-edge AI-driven approaches to spirometry data analysis, revolutionizing at-home testing with instant feedback and heightened efficacy. - Virtual integration of clinicians into participants' homes, ensuring top-notch data quality and engaging participant experiences. - Remote monitoring of lung sounds and their significant impact on respiratory endpoints within clinical trials. - Explore alternative respiratory endpoints that surpass traditional spirometry, providing greater flexibility and a more comprehensive assessment of lung health. ▶️ Watch now and stay ahead in respiratory research! https://hubs.li/Q02FPVsC0 #spirometry #respiratorycare #clinicaltrials #artificialintelligence
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
6d
Report this post
Clario is excited to share that our Chief Information, Technology & Product Officer, Jay Ferro, has been invited to share his expertise in an Executive Fireside Chat at the HMG Strategy Annual Philadelphia C-Level Technology Leadership Summit. If you'll be in Philadelphia on August 15, don't miss this insightful event!
HMG Strategy

10,699 followers
1w

We are excited to announce the 9th Annual Philadelphia C-Level Technology Leadership Summit on August 15, 2024, at the Philadelphia Country Club! Join us for an Executive Fireside Chat with Jay Ferro, EVP, Chief Information & Technology Officer at Clario. This summit promises a day of engaging discussions and valuable networking opportunities with top technology leaders. Register Here: https://lnkd.in/eE5uV_x8 #TechSummit #Leadership #CyberSecurity #Networking #HMGStrategy
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
1w
Report this post
Clario’s Director of eCOA Science Kelly Dumais, Ph. D., will take part in the Critical Path Institute (C-Path)’s next webinar: BYOD, A Guide for Successful Implementation. Don’t miss this comprehensive discussion about optimizing Bring Your Own Device (BYOD) approaches to eCOA in clinical trials. 👇 #clinicaltrials #eCOA
Critical Path Institute (C-Path)

7,756 followers
2w Edited

JOIN US Tuesday, July 18, for an in-depth look at the key considerations around the use of Bring Your Own Device (BYOD) approaches to electronic clinical outcome assessment data collection in clinical trials, developed and presented by members of the BYOD Project Team as part of the eCOA Consortium and PRO Consortium’s eCOA: Getting Better Together Initiative. Register now: https://lnkd.in/gW6gzAU7 Karl McEvoy Kelly Dumais Chris Barden Heather Romero Scottie Kern eCOA members, include: ActiGraph Evinova Clario ICON plc Inspired Health IQVIA Kayentis Koneksa Mapi Research Trust Medable, Inc Medidata Solutions Medrio ObvioHealth Parexel Red Nucleus RWS Group Signant Health Suvoda TransPerfect Life Sciences uMotif WCG YPrime #CPath #eCOA #DHT #ACT #eCOAC #globalhealth #collaboration #drugdevelopment #datasharing #clinicaltrials
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
1w
Report this post
This week, BioSpace published the second part of their three-part podcast series on Diversity, Equity, and Inclusion (DE&I) in drug and medical device development. Our Chief Medical Officer, Todd Rudo, M.D., was invited to participate in the discussion. Check out the most recent episode in which Dr. Rudo and the other panelists continue their discussion about the need for diversity in clinical trials and the life sciences ⬇

BioSpace

112,735 followers
1w Edited

🎙 This week on Denatured, Head of Insights Lori Ellis and guests ⁠⁠Ali Pashazadeh, Treehill Partners; Charlotte Jones-Burton, MD, MS, bluebird bio; Chia Chia Sun⁠⁠⁠, Fab Biopharma; Phyllis Greenberger, and Todd Rudo, Clario discuss the implications of not addressing the DE&I data gaps for the future. https://hubs.li/Q02F78BY0 #podcast #biospace

Understanding That We Don't Understand at a Molecular Level | BioSpace

biospace.com
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
1w
Report this post
Join Clario on July 11 for an insightful webinar on ophthalmology clinical trials. We’ll explore strategies for improving patient access and precision analysis using artificial intelligence (AI). Our experts will cover: • Vendor-agnostic, multi-modality platforms • AI-enabled workflows • Best practices for eCOA implementation in various trial settings ➡️ Register to discover how AI is revolutionizing ophthalmology clinical trials: https://hubs.li/Q02F21pj0 #webinar #artificialintelligence #patientcare #clinicaltrials

6 Comments
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
1w Edited
Report this post
Early phase QT assessment amongst healthy volunteers minimizes QT risk at a fraction of the cost of the TQT study, writes Borje Darpo, MD, PhD. Bolstered by the FDA's S7B/E14 guidance, EPQT is emerging as a standard for assessing cardiac safety. Learn from studies why this is the case in Dr. Darpo’s article: https://hubs.li/Q02DTc-F0
Like Comment
To view or add a comment, sign in
Clario

96,443 followers
2w Edited
Report this post
Clario enjoyed connecting with so many of you in June at the DIA Global Meeting! We were especially excited by the turnout at our Innovation Theater about responsibly using artificial intelligence (#AI) in Clinical Trials. If you weren't able to attend, our Chief Medical Officer, Todd Rudo, M.D.; SVP and General Counsel, Lauren Misztal; and SVP of R&D, Gaurav Josan, spoke on this subject in a webinar earlier this year. Check it out for free and on-demand here: https://hubs.li/Q02DyRJ20 #artificialintelligence #clinicaltrials #innovation
3 Comments
Like Comment
To view or add a comment, sign in

96,443 followers

View Profile Follow

Clario’s Post

More Relevant Posts

Explore topics